@prefix config: . @prefix meta: . @prefix rdf: . @prefix rdfs: . @prefix xsd: . @prefix owl: . @prefix dc: . @prefix dcmitype: . @prefix dcterms: . @prefix foaf: . @prefix geo: . @prefix om: . @prefix locn: . @prefix schema: . @prefix skos: . @prefix dbpedia: . @prefix p: . @prefix yago: . @prefix units: . @prefix geonames: . @prefix prv: . @prefix prvTypes: . @prefix doap: . @prefix void: . @prefix ir: . @prefix ou: . @prefix teach: . @prefix time: . @prefix datex: . @prefix aiiso: . @prefix vivo: . @prefix bibo: . @prefix fabio: . @prefix vcard: . @prefix swrcfe: . @prefix frapo: . @prefix org: . @prefix ei2a: . @prefix pto: . ou:urlOrcid ; dcterms:creator "Duarte J.D."; dcterms:created "2024-10-01T00:00:00"^^xsd:dateTime; bibo:issn "0009-9236"; dcterms:title "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy"; bibo:page_range "939-947"; ou:urlScopus ; bibo:doi "10.1002/cpt.3351"; ou:openaccess "1"^^xsd:boolean; ou:vecesCitado "38"^^xsd:integer; bibo:volume "116"; ou:bibtex "@article{Agundez2024,title = {Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC)~for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy},journal = {Clinical Pharmacology and Therapeutics},year = {2024},volume = {116},number = {4},pages = {939-947},author = {Duarte, J.D. and Thomas, C.D. and Lee, C.R. and Huddart, R. and Agundez, J.A.G. and Baye, J.F. and Gaedigk, A. and Klein, T.E. and Lanfear, D.E. and Monte, A.A. and Nagy, M. and Schwab, M. and Stein, C.M. and Uppugunduri, C.R.S. and van Schaik, R.H.N. and Donnelly, R.S. and Caudle, K.E. and Luzum, J.A.}}"; bibo:eissn "1532-6535"; dcterms:contributor "Duarte J.D. et al."; ou:tipoPublicacion "Article"; a ou:Publicacion; ou:eid "2-s2.0-85197294153"; vcard:url ; fabio:hasPublicationYear "2024"; dcterms:publisher "Clinical Pharmacology and Therapeutics"; vivo:identifier "2024-2920"; ou:publicadaEnRevista , . ou:tienePublicacion .